NVAX logo

Novavax (NVAX) Operating profit

annual operating profit:

-$248.93M+$317.58M(+56.06%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVAX annual operating income is -$248.93 million, with the most recent change of +$317.58 million (+56.06%) on December 31, 2024.
  • During the last 3 years, NVAX annual operating profit has risen by +$1.44 billion (+85.24%).
  • NVAX annual operating profit is now -5667.63% below its all-time high of -$4.32 million, reached on December 31, 2005.

Performance

NVAX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

quarterly operating profit:

$515.51M+$646.59M(+493.28%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX quarterly operating income is $515.51 million, with the most recent change of +$646.59 million (+493.28%) on March 31, 2025.
  • Over the past year, NVAX quarterly operating profit has increased by +$660.34 million (+455.94%).
  • NVAX quarterly operating profit is now at all-time high.

Performance

NVAX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM operating profit:

$411.41M+$660.34M(+265.27%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX TTM operating income is $411.41 million, with the most recent change of +$660.34 million (+265.27%) on March 31, 2025.
  • Over the past year, NVAX TTM operating profit has increased by +$809.99 million (+203.22%).
  • NVAX TTM operating profit is now at all-time high.

Performance

NVAX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

NVAX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.1%+455.9%+203.2%
3 y3 years+85.2%+146.3%+132.4%
5 y5 years-92.1%+2351.4%+466.4%

NVAX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+85.2%at high+206.7%at high+129.3%
5 y5-year-92.1%+85.2%at high+162.5%at high+124.4%
alltimeall time-5667.6%+85.2%at high+162.5%at high+124.4%

NVAX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$515.51M(-493.3%)
$411.41M(-265.3%)
Dec 2024
-$248.93M(-56.1%)
-$131.08M(-2.2%)
-$248.93M(-17.4%)
Sep 2024
-
-$134.02M(-183.2%)
-$301.42M(+2.9%)
Jun 2024
-
$161.00M(-211.2%)
-$293.03M(-26.5%)
Mar 2024
-
-$144.83M(-21.1%)
-$398.57M(-29.6%)
Dec 2023
-$566.51M(-12.1%)
-$183.57M(+46.1%)
-$566.51M(-9.6%)
Sep 2023
-
-$125.63M(-326.5%)
-$626.82M(-0.2%)
Jun 2023
-
$55.46M(-117.7%)
-$628.38M(-46.1%)
Mar 2023
-
-$312.77M(+28.2%)
-$1.17B(+81.0%)
Dec 2022
-$644.74M(-61.8%)
-$243.88M(+91.7%)
-$644.74M(-47.4%)
Sep 2022
-
-$127.19M(-73.7%)
-$1.23B(-12.8%)
Jun 2022
-
-$482.96M(-330.8%)
-$1.41B(+10.8%)
Mar 2022
-
$209.29M(-125.4%)
-$1.27B(-24.8%)
Dec 2021
-$1.69B(+304.7%)
-$824.97M(+168.6%)
-$1.69B(+61.5%)
Sep 2021
-
-$307.14M(-11.2%)
-$1.04B(+12.2%)
Jun 2021
-
-$345.83M(+65.8%)
-$931.26M(+54.6%)
Mar 2021
-
-$208.63M(+14.1%)
-$602.45M(+44.6%)
Dec 2020
-$416.72M(+221.5%)
-$182.85M(-5.7%)
-$416.72M(+58.7%)
Sep 2020
-
-$193.94M(+1039.0%)
-$262.57M(+183.5%)
Jun 2020
-
-$17.03M(-25.6%)
-$92.63M(-17.5%)
Mar 2020
-
-$22.90M(-20.2%)
-$112.27M(-13.4%)
Dec 2019
-$129.60M(-25.5%)
-$28.70M(+19.6%)
-$129.60M(-12.1%)
Sep 2019
-
-$24.00M(-34.5%)
-$147.40M(-10.8%)
Jun 2019
-
-$36.67M(-8.8%)
-$165.30M(-3.1%)
Mar 2019
-
-$40.22M(-13.5%)
-$170.63M(-1.9%)
Dec 2018
-$173.92M(+1.3%)
-$46.51M(+11.0%)
-$173.92M(-0.7%)
Sep 2018
-
-$41.90M(-0.2%)
-$175.19M(+0.2%)
Jun 2018
-
-$41.99M(-3.5%)
-$174.92M(+0.3%)
Mar 2018
-
-$43.51M(-8.9%)
-$174.40M(+1.6%)
Dec 2017
-$171.71M(-36.2%)
-$47.78M(+14.8%)
-$171.71M(-3.5%)
Sep 2017
-
-$41.63M(+0.4%)
-$177.97M(-10.9%)
Jun 2017
-
-$41.47M(+1.6%)
-$199.65M(-14.9%)
Mar 2017
-
-$40.83M(-24.5%)
-$234.68M(-12.8%)
Dec 2016
-$269.11M(+71.2%)
-$54.05M(-14.6%)
-$269.11M(-8.5%)
Sep 2016
-
-$63.31M(-17.2%)
-$293.97M(+11.4%)
Jun 2016
-
-$76.50M(+1.6%)
-$263.86M(+26.7%)
Mar 2016
-
-$75.26M(-4.6%)
-$208.18M(+32.4%)
Dec 2015
-$157.24M(+87.9%)
-$78.90M(+137.7%)
-$157.24M(+42.9%)
Sep 2015
-
-$33.20M(+59.4%)
-$110.00M(+13.9%)
Jun 2015
-
-$20.82M(-14.4%)
-$96.59M(+3.2%)
Mar 2015
-
-$24.31M(-23.2%)
-$93.62M(+11.9%)
Dec 2014
-$83.69M(+59.6%)
-$31.66M(+60.0%)
-$83.69M(+26.3%)
Sep 2014
-
-$19.79M(+10.9%)
-$66.28M(+7.3%)
Jun 2014
-
-$17.85M(+24.1%)
-$61.77M(+8.7%)
Mar 2014
-
-$14.38M(+0.9%)
-$56.81M(+8.4%)
Dec 2013
-$52.43M(+76.8%)
-$14.25M(-6.7%)
-$52.44M(+10.0%)
Sep 2013
-
-$15.28M(+18.5%)
-$47.68M(+21.5%)
Jun 2013
-
-$12.90M(+28.9%)
-$39.25M(+21.9%)
Mar 2013
-
-$10.01M(+5.4%)
-$32.20M(+8.6%)
Dec 2012
-$29.66M(+37.5%)
-$9.49M(+38.6%)
-$29.67M(+21.4%)
Sep 2012
-
-$6.85M(+17.0%)
-$24.43M(+13.4%)
Jun 2012
-
-$5.86M(-21.6%)
-$21.55M(-0.3%)
Mar 2012
-
-$7.47M(+75.3%)
-$21.61M(+0.2%)
Dec 2011
-$21.58M(-43.9%)
-$4.26M(+7.3%)
-$21.58M(-11.4%)
Sep 2011
-
-$3.97M(-33.0%)
-$24.35M(-21.3%)
Jun 2011
-
-$5.92M(-20.3%)
-$30.92M(-10.3%)
Mar 2011
-
-$7.43M(+5.7%)
-$34.47M(-10.5%)
Dec 2010
-$38.49M
-$7.03M(-33.3%)
-$38.49M(-15.6%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$10.54M(+11.3%)
-$45.62M(+5.3%)
Jun 2010
-
-$9.47M(-17.3%)
-$43.34M(+3.9%)
Mar 2010
-
-$11.45M(-19.1%)
-$41.70M(+11.5%)
Dec 2009
-$37.38M(+8.8%)
-$14.15M(+71.3%)
-$37.38M(+15.2%)
Sep 2009
-
-$8.26M(+5.5%)
-$32.44M(-4.3%)
Jun 2009
-
-$7.83M(+9.7%)
-$33.90M(-1.1%)
Mar 2009
-
-$7.14M(-22.5%)
-$34.28M(-0.2%)
Dec 2008
-$34.36M(+13.5%)
-$9.21M(-5.3%)
-$34.36M(+20.8%)
Sep 2008
-
-$9.73M(+18.6%)
-$28.45M(+1.7%)
Jun 2008
-
-$8.20M(+13.6%)
-$27.98M(-1.8%)
Mar 2008
-
-$7.22M(+119.1%)
-$28.50M(-2.1%)
Dec 2007
-$30.27M(+43.4%)
-$3.30M(-64.4%)
-$29.12M(-0.2%)
Sep 2007
-
-$9.26M(+6.1%)
-$29.17M(+13.9%)
Jun 2007
-
-$8.72M(+11.3%)
-$25.61M(+7.1%)
Mar 2007
-
-$7.84M(+134.1%)
-$23.92M(+13.3%)
Dec 2006
-$21.12M(+389.2%)
-$3.35M(-41.2%)
-$21.12M(+240.4%)
Sep 2006
-
-$5.69M(-19.1%)
-$6.20M(+125.8%)
Jun 2006
-
-$7.04M(+39.8%)
-$2.75M(+194.1%)
Mar 2006
-
-$5.04M(-143.5%)
-$934.00K(-78.4%)
Dec 2005
-$4.32M(-82.4%)
$11.56M(-616.9%)
-$4.32M(-83.3%)
Sep 2005
-
-$2.24M(-57.2%)
-$25.79M(-0.3%)
Jun 2005
-
-$5.22M(-37.9%)
-$25.87M(-7.6%)
Mar 2005
-
-$8.42M(-15.0%)
-$27.98M(+14.4%)
Dec 2004
-$24.46M(+52.4%)
-$9.91M(+327.1%)
-$24.46M(+38.9%)
Sep 2004
-
-$2.32M(-68.4%)
-$17.62M(-3.5%)
Jun 2004
-
-$7.34M(+49.9%)
-$18.26M(+17.4%)
Mar 2004
-
-$4.90M(+60.0%)
-$15.55M(-3.1%)
Dec 2003
-$16.05M(-25.5%)
-$3.06M(+3.4%)
-$16.05M(-6.0%)
Sep 2003
-
-$2.96M(-36.1%)
-$17.09M(-17.1%)
Jun 2003
-
-$4.63M(-14.2%)
-$20.60M(-4.1%)
Mar 2003
-
-$5.40M(+32.0%)
-$21.49M(-0.3%)
Dec 2002
-$21.56M(+132.9%)
-$4.09M(-36.8%)
-$21.56M(+5.1%)
Sep 2002
-
-$6.48M(+17.5%)
-$20.52M(+25.0%)
Jun 2002
-
-$5.51M(+0.7%)
-$16.41M(+30.5%)
Mar 2002
-
-$5.47M(+79.6%)
-$12.58M(+35.9%)
Dec 2001
-$9.26M(-27.4%)
-$3.05M(+28.5%)
-$9.26M(-18.0%)
Sep 2001
-
-$2.37M(+41.0%)
-$11.29M(-8.2%)
Jun 2001
-
-$1.68M(-21.9%)
-$12.29M(-8.5%)
Mar 2001
-
-$2.15M(-57.7%)
-$13.44M(+5.5%)
Dec 2000
-$12.74M(+177.0%)
-$5.08M(+50.6%)
-$12.74M(+45.5%)
Sep 2000
-
-$3.38M(+19.4%)
-$8.76M(+21.9%)
Jun 2000
-
-$2.83M(+94.3%)
-$7.18M(+39.3%)
Mar 2000
-
-$1.46M(+32.3%)
-$5.16M(+12.1%)
Dec 1999
-$4.60M(-11.5%)
-$1.10M(-38.9%)
-$4.60M(-11.5%)
Sep 1999
-
-$1.80M(+125.0%)
-$5.20M(+10.6%)
Jun 1999
-
-$800.00K(-11.1%)
-$4.70M(-9.6%)
Mar 1999
-
-$900.00K(-47.1%)
-$5.20M(0.0%)
Dec 1998
-$5.20M(+8.3%)
-$1.70M(+30.8%)
-$5.20M(+13.0%)
Sep 1998
-
-$1.30M(0.0%)
-$4.60M(+2.2%)
Jun 1998
-
-$1.30M(+44.4%)
-$4.50M(0.0%)
Mar 1998
-
-$900.00K(-18.2%)
-$4.50M(-4.3%)
Dec 1997
-$4.80M(-12.7%)
-$1.10M(-8.3%)
-$4.70M(-13.0%)
Sep 1997
-
-$1.20M(-7.7%)
-$5.40M(+3.8%)
Jun 1997
-
-$1.30M(+18.2%)
-$5.20M(0.0%)
Mar 1997
-
-$1.10M(-38.9%)
-$5.20M(0.0%)
Dec 1996
-$5.50M
-$1.80M(+80.0%)
-$5.20M(+52.9%)
Sep 1996
-
-$1.00M(-23.1%)
-$3.40M(+41.7%)
Jun 1996
-
-$1.30M(+18.2%)
-$2.40M(+118.2%)
Mar 1996
-
-$1.10M
-$1.10M

FAQ

  • What is Novavax annual operating income?
  • What is the all time high annual operating profit for Novavax?
  • What is Novavax annual operating profit year-on-year change?
  • What is Novavax quarterly operating income?
  • What is the all time high quarterly operating profit for Novavax?
  • What is Novavax quarterly operating profit year-on-year change?
  • What is Novavax TTM operating income?
  • What is the all time high TTM operating profit for Novavax?
  • What is Novavax TTM operating profit year-on-year change?

What is Novavax annual operating income?

The current annual operating profit of NVAX is -$248.93M

What is the all time high annual operating profit for Novavax?

Novavax all-time high annual operating income is -$4.32M

What is Novavax annual operating profit year-on-year change?

Over the past year, NVAX annual operating income has changed by +$317.58M (+56.06%)

What is Novavax quarterly operating income?

The current quarterly operating profit of NVAX is $515.51M

What is the all time high quarterly operating profit for Novavax?

Novavax all-time high quarterly operating income is $515.51M

What is Novavax quarterly operating profit year-on-year change?

Over the past year, NVAX quarterly operating income has changed by +$660.34M (+455.94%)

What is Novavax TTM operating income?

The current TTM operating profit of NVAX is $411.41M

What is the all time high TTM operating profit for Novavax?

Novavax all-time high TTM operating income is $411.41M

What is Novavax TTM operating profit year-on-year change?

Over the past year, NVAX TTM operating income has changed by +$809.99M (+203.22%)
On this page